A motor regulatory protein can block human ovarian tumor growth, leading to eventual cancer cell death and possible new therapies to treat the disease, according to researchers. . ...>Read More... [1]
A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study finds. . ...>Read More... [2]
High-grade serous ovarian cancer is thought by many scientists to often be a fallopian tube malignancy masquerading as an ovarian one. While most of the evidence linking the cancer to the fallopian tubes has so far been only circumstantial, a new study suggests there is a direct connection, a finding that could aid in the development of better treatments. . ...>Read More... [3]
An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer cells and significantly increases survival in an ovarian cancer mouse model, a study has found. . ...>Read More... [4]
New research suggests that a layer of cells, which serve as the "breeding ground" for ovarian cancer, may be removed yet allow the women to have children. This would be a vast improvement over the current prevention strategy for women at high risk for ovarian cancer: Removal of the ovaries entirely. . ...>Read More... [5]
Women with ovarian cancer who have the BRCA2 gene mutation are more likely to survive the malignancy than women with the BRCA1 mutation, or women without either mutation, according to new research. . ...>Read More... [6]
Measuring the mechanical strength of cancer cell mucus layers provides clues about better ways to treat cancer, and also suggests why some cancer cells are more resistant to drugs than others, according to new research. Healthy tissues naturally secrete mucus to protect against infection. Cancer cells, however, produce far more mucus than healthy cells. . ...>Read More... [7]
Researchers have zeroed in on a genetic process that may allow ovarian cancer to resist chemotherapy. . ...>Read More... [8]
Family doctors can take more than a month to record ovarian cancer, once diagnosed by a specialist, in one in 10 cases examined in the U.K. . ...>Read More... [9]
Cancer researchers have discovered that a type of regulatory RNA may be effective in fighting ovarian cancer. This new discovery may allow physicians to turn back the clock of the tumor's life cycle to a phase where traditional chemotherapy can better do its job. . ...>Read More... [10]
Links:
[1] http://www.careultimate.com/node/38937
[2] http://www.careultimate.com/node/38938
[3] http://www.careultimate.com/node/38939
[4] http://www.careultimate.com/node/38940
[5] http://www.careultimate.com/node/38941
[6] http://www.careultimate.com/node/38942
[7] http://www.careultimate.com/node/38943
[8] http://www.careultimate.com/node/38944
[9] http://www.careultimate.com/node/38945
[10] http://www.careultimate.com/node/38946
[11] http://www.careultimate.com/cancer_news?page=1
[12] http://www.careultimate.com/cancer_news?page=2
[13] http://www.careultimate.com/cancer_news?page=3
[14] http://www.careultimate.com/cancer_news?page=4
[15] http://www.careultimate.com/cancer_news?page=5
[16] http://www.careultimate.com/cancer_news?page=6
[17] http://www.careultimate.com/cancer_news?page=7
[18] http://www.careultimate.com/cancer_news?page=8
[19] http://www.careultimate.com/cancer_news?page=248